Article Details

Altimmune Poised to Begin Phase 1 Clinical Trial of Single-Dose Intranasal COVID-19 Vaccine

Retrieved on: 2020-11-25 22:07:30

Tags for this article:

Click the tags to see associated articles and topics

Altimmune Poised to Begin Phase 1 Clinical Trial of Single-Dose Intranasal COVID-19 Vaccine. View article details on hiswai:

Excerpt

Preclinical studies for Altimmune showed that AdCOVID stimulated a broad <b>immune response</b>, including both systemic immunity — as shown by ...

Article found on: globalbiodefense.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up